Azienda Ospedaliera Univ. Policlinico Gaspare Rodolico

Catania 95125

0 studies enrolling now · 1 studies all time

What they study most

Breast Cancer

Studies at this site

• Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04] — Running, not enrolling